Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Spine J. 2013 Oct 16;14(7):1106–1116. doi: 10.1016/j.spinee.2013.07.468

Table 4.

Secondary Outcomes

Observed unadjusted Mean (SD)
Slope (95%CI) Adjusted Mean difference (95% CI)
SMT 0 SMT 6 SMT 12 SMT 18 per 6 SMT sessions SMT 0 vs SMT 6 SMT 0 vs SMT 12 SMT 0 vs SMT 18
Pain unpleasantness (0-100 scale)
    0 wk 41.7 (19.5) 41.1 (21.1) 40.3 (22.8) 42.4 (22.2)
    6 wk 24.7 (21.7) 20.3 (17.5) 15.6 (17.3) 18.4 (18.1) 2.4 (0.9, 4.0)* 4.2 (−0.8, 9.1) 8.7 (3.5, 14.0)* 6.6(1.7, 11.6)*
    12 wk 29.7 (22.3) 24.5 (20.6) 22.2 (22.3) 23.9 (21.3) 2.0 (0.2, 3.7) 4.8 (−1.0, 10.5) 7.1 (1.1, 13.0)* 5.8 (0.1, 11.5)
    18 wk 26.8 (22.3) 21.9 (21.2) 20.4 (20.4) 21.3 (21.8) 1.8 (0.1, 3.6,) 4.6 (−1.0, 10.3) 5.8 (0.4, 11.2) 5.8 (0.4, 11.2)
    24 wk 27.4 (21.7) 24.8 (21.8) 25.0 (21.9) 24.8 (22.4) 0.7 (−1.1, 2.5) 2.1 (−3.5, 7.8) 2.0 (−3.6, 7.5) 2.5 (−3.2, 8.3)
    39 wk 28.3 (21.6) 25.5 (21.3) 23.2 (20.8) 23.0 (21.1) 1.8 (0.1, 3.6) 2.4 (−3.3, 8.2) 4.8 (−0.6, 10.3) 5.4 (−0.2, 10.9)
    52 wk 27.8 (22.1) 22.1 (21.7) 24.0 (24.0) 21.5 (19.9) 1.7 (−0.1, 3.5) 5.4 (−0.3, 11.2) 3.7 (−2.4, 9.7) 6.4 (0.7, 12.1)
Days with pain (last 4 wk)
    0 wk 24.8 (4.8) 24.1 (5.5) 23.3 (5.7) 24.1 (4.6)
    6 wk 18.9 (10.0) 17.6 (10.6) 15.0 (10.1) 16.3 (10.8) 0.8 (−0.0, 1.7) 0.9 (−1.8, 3.5) 3.0 (0.3, 5.6) 2.2 (−0.6, 4.9)
    12 wk 18.1 (9.5) 17.4 (9.2) 15.5 (9.7) 14.7 (10.2) 1.1 (0.2, 1.9)* 0.4 (−2.0, 2.8) 1.9 (−0.7, 4.5) 3.0 (0.5, 5.6)*
    18 wk 17.4 (10.2) 17.6 (10.3) 15.5 (10.3) 14.9 (10.6) 0.8 (−0.0, 1.7) −0.6 (−3.2, 2.1) 1.2 (−1.5, 3.9) 2.2 (−0.6, 4.9)
    24 wk 16.9 (10.0) 16.5 (10.3) 15.4 (9.5) 13.5 (9.6) 1.0 (0.2, 1.8)* 0.1 (−2.5, 2.7) 0.7 (−1.8, 3.3) 3.1 (0.5, 5.7)*
    39 wk 17.7 (9.8) 15.6 (9.9) 15.1 (10.4) 14.3 (10.6) 0.9 (0.1, 1.7) 1.7 (−0.8, 4.2) 1.7 (−0.8, 4.3) 3.0 (0.4, 5.6)
    52 wk 17.0 (10.2) 15.3 (10.3) 14.0 (10.6) 13.6 (10.4) 1.0 (0.1, 1.8)* 1.3 (−1.4, 3.9) 2.1 (−0.7, 4.9) 3.0 (0.3, 5.7)
Days with disability (last 4 wk)
    0 wk 7.4 (8.1) 6.7 (7.5) 6.8 (7.5) 6.5 (7.2)
    6 wk 2.4 (5.5) 1.6 (3.0) 1.3 (2.7) 1.2 (3.4) 0.3 (−0.0, 0.7) 0.8 (−0.4, 1.9) 1.0 (−0.1, 2.2) 1.1 (−0.1, 2.3)
    12 wk 3.4 (5.9) 2.6 (4.9) 2.0 (3.3) 2.3 (3.7) 0.4 (−0.0, 0.7) 0.6 (−0.7, 1.9) 1.3 (0.0, 2.5) 1.0 (−0.3, 2.2)
    18 wk 2.1 (5.3) 2.2 (5.0) 1.8 (4.1) 2.1 (4.9) 0.1 (−0.4, 0.5) −0.1 (−1.4, 1.3) 0.3 (−0.9, 1.6) 0.0 (−1.3, 1.4)
    24 wk 3.5 (6.7) 2.7 (5.1) 2.8 (4.6) 2.8 (4.2) 0.1 (−0.3, 0.6) 0.7 (−0.7, 2.1) 0.6 (−0.8, 2.1) 0.5 (−0.9, 1.9)
    39 wk 2.8 (5.1) 3.0 (5.5) 2.4 (4.7) 2.5 (4.8) 0.1 (−0.3, 0.5) −0.3 (−1.7, 1.1) 0.4 (−0.9, 1.6) 0.2 (−1.1, 1.5)
    52 wk 3.4 (6.0) 3.4 (6.9) 1.9 (3.7) 2.4 (4.7) 0.4 (−0.1, 0.8) −0.1 (−1.7, 1.4) 1.5 (0.2, 2.8) 0.8 (−0.6, 2.1)
Perceived pain change (6-pt Likert)
    6 wk 3.7 (0.9) 4.1 (0.9) 4.3 (1.0) 4.3 (1.0) 0.1 (0.1, 0.2)* 0.2 (−0.0, 0.5) 0.4 (0.2, 0.7)* 0.4 (0.1, 0.7)*
    12 wk 3.7 (0.9) 3.8 (0.9) 4.0 (1.0) 4.0 (0.9) 0.1 (0.0, 0.2) 0.1 (−0.1, 0.4) 0.3 (−0.0, 0.5) 0.3 (0.0, 0.5)
    18 wk 3.7 (0.9) 4.0 (1.0) 4.1 (1.0) 4.0 (1.0) 0.1 (−0.0, 0.2) 0.2 (−0.0, 0.5) 0.4 (0.1, 0.7)* 0.2 (−0.0, 0.5)
    24 wk 3.8 (1.0) 3.9 (1.0) 3.9 (1.0) 3.9 (1.0) 0.0 (−0.1, 0.1) 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.3)
    39 wk 3.7 (1.0) 3.8 (1.1) 4.0 (1.0) 4.0 (0.9) 0.1 (0.0, 0.2) 0.1 (−0.2, 0.4) 0.3 (0.0, 0.6) 0.3 (0.0, 0.5)
    52 wk 3.7 (0.9) 4.0 (1.1) 3.9 (1.1) 4.0 (0.9) 0.1 (−0.0, 0.1) 0.3 (0.0, 0.6) 0.2 (−0.1, 0.5) 0.2 (−0.0, 0.5)
Perceived disability change (6-pt Likert)
    6 wk 3.6 (0.9) 3.9 (0.9) 4.0 (1.0) 4.0 (0.9) 0.1 (0.0, 0.2)* 0.3 (0.0, 0.5) 0.4 (0.1, 0.6)* 0.4 (0.2, 0.6)*
    12 wk 3.5 (0.9) 3.8 (0.9) 3.8 (1.0) 3.8 (0.9) 0.1 (0.0, 0.2)* 0.2 (0.0, 0.5) 0.3 (0.0, 0.5) 0.3 (0.0, 0.5)
    18 wk 3.6 (0.8) 3.7 (1.0) 3.8 (1.0) 3.8 (0.9) 0.1 (−0.0, 0.2) 0.1 (−0.2, 0.3) 0.2 (−0.1, 0.4) 0.2 (−0.0, 0.5)
    24 wk 3.6 (0.9) 3.7 (0.9) 3.7 (0.9) 3.7 (1.0) 0.0 (−0.1, 0.1) 0.1 (−0.2, 0.3) 0.1 (−0.2, 0.3) 0.1 (−0.2, 0.4)
    39 wk 3.6 (0.9) 3.7 (1.0) 3.9 (1.0) 3.9 (0.9) 0.1 (0.0, 0.2)* 0.1 (−0.2, 0.4) 0.3 (0.1, 0.6)* 0.3 (0.0, 0.5)*
    52 wk 3.6 (0.9) 3.8 (1.0) 3.8 (1.1) 3.9 (0.9) 0.1 (−0.0, 0.2) 0.2 (−0.0, 0.5) 0.2 (−0.1, 0.5) 0.3 (0.0, 0.3)
SF-12 physical health component
    0 wk 43.0 (9.5) 43.8 (8.9) 44.3 (8.4) 42.3 (8.8)
    12 wk 45.5 (10.3) 47.1 (8.2) 49.6 (8.5) 47.5 (8.5) 1.0 (0.3, 1.6)* 1.2 (−0.8, 3.3) 3.5 (1.3, 5.7)* 2.4 (0.3, 4.6)
    24 wk 50.0 (11.1) 50.5 (10.1) 51.4 (9.1) 50.9 (9.4) 0.5 (−0.3, 1.2) 0.0 (−2.3, 2.4) 0.8 (−1.6, 3.2) 1.3 (−1.1, 3.6)
    39 wk 50.6 (11.5) 51.1 (10.3) 52.7 (9.6) 51.8 (9.3) 0.6 (−0.2, 1.4) 0.1 (−2.3, 2.4) 1.5 (−0.9, 4.0) 1.6 (−0.9, 4.0)
    52 wk 50.7 (12.0) 50.8 (11.0) 52.6 (10.3) 52.5 (8.5) 0.8 (0.1, 1.6) 0.3 (−2.7, 2.1) 1.4 (−1.2, 4.0) 2.2 (−0.2, 4.5)
SF-12 mental health component
    0 wk 50.2 (10.5) 48.6 (10.5) 47.6 (11.2) 49.4 (9.6)
    12 wk 50.2 (10.8) 50.4 (9.4) 47.8 (11.0) 48.0 (9.8) −0.7 (−1.3, −0.0) 1.3 (−0.7, 3.3) −0.5 (−2.6, 1.5) −1.5 (−3.5, 0.4)
    24 wk 51.8 (10.9) 52.8 (10.2) 50.8 (11.8) 51.3 (11.2) −0.1 (−0.8, 0.6) 2.1 (−0.0, 4.2) 0.7 (−1.3, 2.8) 0.1 (−2.1, 2.2)
    39 wk 51.7 (11.3) 51.5 (11.6) 49.2 (13.6) 49.0 (11.7) −0.8 (−1.5, −0.0) 1.1 (−1.3, 3.4) −0.4 (−2.9, 2.1) −2.0 (−4.3, 0.3)
    52 wk 51.3 (12.0) 50.4 (11.4) 50.6 (12.7) 50.4 (11.7) −0.0 (−0.8, 0.8) 0.2 (−2.3, 2.7) 1.1 (−1.6, 3.7) −0.3 (−2.9, 2.3)
EuroQol Health State (0-100 scale)
    0 wk 70.1 (17.2) 72.1 (13.8) 73.5 (14.4) 68.2 (17.4)
    12 wk 73.5 (17.3) 78.4 (14.1) 77.9 (15.0) 75.7 (14.5) 0.8 (−0.4, 2.0) 3.9 (0.0, 7.7) 2.7 (−1.3, 6.7) 3.1 (−0.8, 6.9)
    24 wk 73.9 (17.5) 77.8 (15.5) 77.0 (15.4) 74.5 (16.7) 0.3 (−1.0, 1.6) 2.9 (−1.0, 6.9) 1.4 (−2.6, 5.5) 1.5 (−2.7, 5.8)
    39 wk 73.1 (20.0) 76.8 (17.2) 76.6 (15.6) 75.3 (16.8) 0.9 (−0.5, 2.3) 2.6 (−1.9, 7.0) 1.8 (−2.6, 6.2) 3.2 (−1.3, 7.6)
    52 wk 74.8 (17.0) 77.1 (17.0) 77.3 (15.3) 77.2 (14.9) 1.0 (−0.3, 2.2) 1.3 (−2.7, 5.4) 0.9 (−3.1, 4.9) 3.3 (−0.5, 7.2)
Non-prescription medication (times in last 4 wk)
    0 wk 7.6 (10.0) 8.9 (10.8) 9.5 (10.0) 7.6 (9.4)
    6 wk 4.3 (6.8) 4.1 (6.9) 4.0 (6.7) 4.0 (8.3) 0.1 (−0.5, 0.7) 0.6 (−1.2, 2.4) 0.9 (−0.8, 2.6) 0.3 (−1.5, 2.1)
    12 wk 7.8 (11.0) 7.1 (23.0) 5.8 (7.6) 7.8 (25.8) 0.1 (−1.6, 1.8) 1.4 (−2.7, 5.6) 3.2 (0.4, 5.9)* −0.1 (−5.5, 5.3)
    18 wk 5.7 (7.4) 6.0 (10.4) 5.3 (9.1) 5.5 (9.1) 0.2 (−0.5, 0.8) 0.1 (−2.4, 2.6) 1.0 (−1.1, 3.2) 0.2 (−1.8, 2.2)
    24 wk 8.1 (13.7) 7.7 (15.8) 6.5 (8.6) 6.4 (10.8) 0.7 (−0.4, 1.7) 0.9 (−3.3, 5.1) 2.4 (−0.7, 5.5) 1.8 (−1.5, 5.0)
    39 wk 7.2 (14.2) 7.4 (12.2) 6.6 (8.9) 7.7 (13.5) −0.0 (−1.1, 1.1) 0.3 (−3.4, 4.0) 1.4 (−1.9, 4.7) −0.5 (−4.0, 3.1)
    52 wk 6.5 (8.0) 6.6 (13.7) 6.7 (9.3) 6.8 (12.7) −0.1 (−0.9, 0.8) 0.3 (−2.7, 3.4) 0.6 (−1.5, 2.6) −0.3 (−2.9, 2.4)

SMT, spinal manipulative therapy group.

Unadjusted group means are from original data without imputation; slopes and group differences are computed from imputed data adjusted for the baseline covariates. Positive signs of slopes and mean differences were computed to favor higher doses of SMT.

*

P < .025

Likert scale: much worse = 1, worse = 2, about the same = 3, better = 4, much better = 5, and completely recovered = 6.